Evidence map›Paper›PMID 24436056›Full record

ArticleMolecular neurobiology2014

Amyloid β-peptide 1-42 modulates the proliferation of mouse neural stem cells: upregulation of fucosyltransferase IX and notch signaling.

Yutaka Itokazu, Robert K Yu

Open access · greenAbstract read
In one paragraph

Article in Molecular neurobiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Neurogenesis Is Increased in Human Neural Stem Cells by Aβ40 Peptide.International journal of molecular sciences · 2022
    Article
  6. Article
  7. Article
  8. Novel neuroprotective peptides in the venom of the solitary scoliid waspThe journal of venomous animals and toxins including tropical diseases · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Gangliosides in Nerve Cell Specification.Progress in molecular biology and translational science · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yutaka ItokazuInstitute of Molecular Medicine and Genetics and Institute of Neuroscience, Medical College of Georgia, Georgia Regents University, Augusta, GA, 30912, USA.
Robert K Yu
Charlie Norwood VA Medical Center · USGeorgia Regents Medical Center · US

Funding

Spingoglycolipids of normal and pathological brainsR01NS011853 · NINDS · YALE UNIVERSITY · PI YU, ROBERT K. · 1985 to 2010
$3.5M
ROLE OF GLYCOLIPIDS IN EXPERIMENTAL NEUROPATHYR01NS026994 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI YU, ROBERT K. · 1988 to 2012
$3.3M
Effects of Gangliosides on Neural Stem Cells: Role in NeuroregenerationI01BX001388 · VA · CHARLIE NORWOOD VA MEDICAL CENTER · PI YU, ROBERT K. · 2012 to 2015
–
BLRD VA I01 BX001388NINDS NIH HHS R01 NS011853NINDS NIH HHS R01 NS026994NINDS NIH HHS R01 NS11853NINDS NIH HHS R01NS26994
6 · The paper itself

Abstract

Amyloid β-peptides (Aβs) aggregate to form amyloid plaques, also known as senile plaques, which are a major pathological hallmark of Alzheimer's disease (AD). Aβs are reported to possess proliferation effects on neural stem cells (NSCs); however, this effect remains controversial. Thus, clarification of their physiological function is an important topic. We have systematically evaluated the effects of several putative bioactive Aβs (Aβ1-40, Aβ1-42, and Aβ25-35) on NSC proliferation. Treatment of NSCs with Aβ1-42 significantly increased the number of those cells (149 ± 10 %). This was not observed with Aβ1-40 which did not have any effects on the proliferative property of NSC. Aβ25-35, on the other hand, exhibited inhibitory effects on cellular proliferation. Since cell surface glycoconjugates, such as glycolipids, glycoproteins, and proteoglycans, are known to be important for maintaining cell fate determination, including cellular proliferation, in NSCs and they undergo dramatic changes during differentiation, we examined the effect of Aβs on a number of key glycoconjugate metabolizing enzymes. Significantly, we found for the first time that Aβ1-42 altered the expression of several key glycosyltransferases and glycosidases, including fucosyltransferase IX (FUT9), sialyltransferase III (ST-III), glucosylceramide ceramidase (GLCC), and mitochondrial sialidase (Neu4). FUT9 is a key enzyme for the synthesis of the Lewis X carbohydrate epitope, which is known to be expressed in stem cells. Aβ1-42 also stimulated the Notch1 intracellular domain (NICD) by upregulation of the expression of Musashi-1 and the paired box protein, Pax6. Thus, Aβ1-42 upregulates NSC proliferation by modulating the expression of several glycogenes involved in Notch signaling.

Indexed as

Up-RegulationAmyloid beta-PeptidesAnimalsCell ProliferationEye ProteinsFucosyltransferasesHomeodomain ProteinsMiceNerve Tissue ProteinsNeural Stem CellsPaired Box Transcription FactorsPAX6 Transcription FactorPeptide FragmentsReceptors, NotchRepressor ProteinsRNA-Binding ProteinsAmyloid beta-Peptidesamyloid beta-protein (1-42)Eye Proteinsfucosyltransferase 9, mouseFucosyltransferasesHomeodomain ProteinsMsi1h protein, mouseNerve Tissue ProteinsPaired Box Transcription FactorsPax6 protein, mousePAX6 Transcription FactorPeptide FragmentsReceptors, NotchRepressor ProteinsRNA-Binding Proteins

Identifiers

PMID24436056
PMCPMC4102671
OpenAlexW2047573089

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.